2023
Rana I, Kataria S, Tan TLin, Hajam EYousaf, Kashyap DKumar, Saha D, Ajnabi J, Paul S, Jayappa S, Ananthan ASHP, Kumar P, Zaarour RF, Haarshaadri J, Kansagara G, Rizvi A, Zirmire RK, Badarinath K, Khedkar SUday, Chandra Y, Samuel R et al..
2023. Mindin (SPON2) Is Essential for Cutaneous Fibrogenesis in a Mouse Model of Systemic Sclerosis.. J Invest Dermatol. 143(5):699-710.e10. DOI:10.1016/j.jid.2022.10.011.
2022
Chatterjee A, Paul S, Bisht B, Bhattacharya S, Sivasubramaniam S, Paul MK.
2022. Advances in targeting the WNT/β-catenin signaling pathway in cancer.. Drug Discov Today. 27(1):82-101. DOI:10.1016/j.drudis.2021.07.007.
Turabi KShahab, Deshmukh A, Paul S, Swami D, Siddiqui S, Kumar U, Naikar S, Devarajan S, Basu S, Paul MK, Aich J.
2022. Drug repurposing-an emerging strategy in cancer therapeutics.. Naunyn Schmiedebergs Arch Pharmacol. 395(10):1139-1158. DOI:10.1007/s00210-022-02263-x.
Paul S, Kumar SMani Dines, Syamala SSoman, Balakrishnan S, Vijayan V, Arumugaswami V, Sudhakar S.
2022. Identification, tissue specific expression analysis and functional characterization of arrestin gene (ARRDC) in the earthworm Eudrilus eugeniae: a molecular hypothesis behind worm photoreception.. Mol Biol Rep. 49(6):4225-4236. DOI:10.1007/s11033-022-07256-w.
Paul S, Balakrishnan S, Arumugaperumal A, Lathakumari S, Syamala SSoman, Vijayan V, Durairaj SChristyraj, Arumugaswami V, Sivasubramaniam S.
2022. Importance of clitellar tissue in the regeneration ability of earthworm Eudrilus eugeniae.. Funct Integr Genomics. 22(4):1-32. DOI:10.1007/s10142-022-00849-5.
2021
Kumavath R, Paul S, Pavithran H, Paul MK, Ghosh P, Barh D, Azevedo V.
2021. Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics.. Biomolecules. 11(9) DOI:10.3390/biom11091275.
Jain PKumar, Jayappa S, Sairam T, Mittal A, Paul S, Rao VJ, Chittora H, Kashyap DK, Palakodeti D, Thangaraj K, Shenthar J, Koranchery R, Rajendran R, Alireza H, Mohanan KSreedharan, Rathinavel A, Dhandapany PS.
2021. Ribosomal protein S6 kinase beta-1 gene variants cause hypertrophic cardiomyopathy.. J Med Genet. DOI:10.1136/jmedgenet-2021-107866.